Stay updated on TAK-659 in AML Clinical Trial

Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-659 in AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Core content updated with a government operating status notice and a new version tag; a specific disease resource entry was removed.
    Difference
    2%
    Check dated 2025-10-06T04:23:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.0%
    Check dated 2025-09-28T23:42:50.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T09:59:50.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T07:56:36.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has added significant information regarding a facility and its location, as well as new publications related to acute myeloid leukemia and the drug TAK-659, while removing references to certain diseases and location details.
    Difference
    3%
    Check dated 2025-08-31T01:05:08.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-23T21:57:18.000Z thumbnail image

Stay in the know with updates to TAK-659 in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.